In this way, it reminds us of the situation of opioid-induced constipation, where the current guidelines still recommend laxatives as first-line therapy [72,73] instead of recommending the treatment with peripherally mu opioid receptor antagonists (PAMORAs). This evidence concerns the gene OPRM1 and Constipation.